Kokici J, Preechanukul A, Arellano-Ballestero H, Gorou F, Peppa D
Viruses. 2024; 16(11).
PMID: 39599860
PMC: 11599065.
DOI: 10.3390/v16111746.
Asenjo J, Moraru M, Al-Akioui-Sanz K, Altadill M, Muntasell A, Lopez-Botet M
HLA. 2024; 104(5):e15764.
PMID: 39581700
PMC: 11586157.
DOI: 10.1111/tan.15764.
Zamora D, Dasgupta S, Stevens-Ayers T, Edmison B, Winston D, Razonable R
JCI Insight. 2024; 9(18).
PMID: 39099206
PMC: 11457861.
DOI: 10.1172/jci.insight.180115.
Basilio-Queiros D, Mischak-Weissinger E
Front Immunol. 2023; 14:1172437.
PMID: 37275911
PMC: 10232812.
DOI: 10.3389/fimmu.2023.1172437.
Krebs P, Peng H, Duhan V
Front Immunol. 2023; 14:1175111.
PMID: 36999011
PMC: 10043422.
DOI: 10.3389/fimmu.2023.1175111.
Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications.
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz). 2023; 71(1):9.
PMID: 36899273
PMC: 10004456.
DOI: 10.1007/s00005-023-00674-z.
Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko R, Mailliard R
J Leukoc Biol. 2023; 113(2):109-138.
PMID: 36822173
PMC: 10043732.
DOI: 10.1093/jleuko/qiac007.
A high-dimensional cytometry atlas of peripheral blood over the human life span.
Jalali S, Harpur C, Piers A, Auladell M, Perriman L, Li S
Immunol Cell Biol. 2022; 100(10):805-821.
PMID: 36218032
PMC: 9828744.
DOI: 10.1111/imcb.12594.
High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV.
Alsulami K, Sadouni M, Tremblay-Sher D, Baril J, Trottier B, Dupuy F
Medicine (Baltimore). 2022; 101(38):e30794.
PMID: 36197157
PMC: 9509172.
DOI: 10.1097/MD.0000000000030794.
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
Vollmers S, Lobermeyer A, Niehrs A, Fittje P, Indenbirken D, Nakel J
Front Immunol. 2022; 13:922252.
PMID: 35911762
PMC: 9334850.
DOI: 10.3389/fimmu.2022.922252.
NK Cells in Protection from HIV Infection.
Bernard N, Alsulami K, Pavey E, Dupuy F
Viruses. 2022; 14(6).
PMID: 35746615
PMC: 9231282.
DOI: 10.3390/v14061143.
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.
Bernard N, Kant S, Kiani Z, Tremblay C, Dupuy F
Front Immunol. 2022; 13:879124.
PMID: 35720328
PMC: 9205404.
DOI: 10.3389/fimmu.2022.879124.
Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells.
Gao F, Zhou Z, Lin Y, Shu G, Yin G, Zhang T
Front Immunol. 2022; 13:830396.
PMID: 35464486
PMC: 9022632.
DOI: 10.3389/fimmu.2022.830396.
Assessment of NKG2C copy number variation in HIV-1 infection susceptibility, and considerations about the potential role of lacking receptors and virus infection.
Toson B, Michita R, Matte M, Soares R, Lawisch G, Mattevi V
J Hum Genet. 2022; 67(8):475-479.
PMID: 35314764
PMC: 8938163.
DOI: 10.1038/s10038-022-01029-w.
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.
Ivison G, Vendrame E, Martinez-Colon G, Ranganath T, Vergara R, Zhao N
Front Cell Infect Microbiol. 2022; 12:757846.
PMID: 35223535
PMC: 8866573.
DOI: 10.3389/fcimb.2022.757846.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Cuapio A, Boulouis C, Filipovic I, Wullimann D, Kammann T, Parrot T
Mol Med. 2022; 28(1):20.
PMID: 35135470
PMC: 8822735.
DOI: 10.1186/s10020-022-00443-2.
The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections.
Martini F, Champagne E
Viruses. 2021; 13(12).
PMID: 34960641
PMC: 8704314.
DOI: 10.3390/v13122372.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Vieira V, Adland E, Malone D, Martin M, Groll A, Ansari M
PLoS Pathog. 2021; 17(11):e1010090.
PMID: 34793581
PMC: 8639058.
DOI: 10.1371/journal.ppat.1010090.
TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4 T cells.
Holder K, Burt K, Grant M
Clin Transl Immunology. 2021; 10(10):e1348.
PMID: 34707863
PMC: 8527024.
DOI: 10.1002/cti2.1348.
Natural killer cells and unconventional T cells in COVID-19.
Bjorkstrom N, Ponzetta A
Curr Opin Virol. 2021; 49:176-182.
PMID: 34217135
PMC: 8214213.
DOI: 10.1016/j.coviro.2021.06.005.